0
Title
User
LIVE NOW
LIVE NOW
Title
User
Sign In
Home
Trending
Sign In
Audios and Videos
Videos
Audios
Channels
Browse Channels
Categories
Acute Lymphoblastic Leukemia
5637
Acute Myelogenous Leukemia
149
Bladder Cancer
49
Bone Metastases
1
Brain Cancer
16
Breast Cancer
121
Business Management
2
Cervical Cancer
2
Chronic Lymphocytic Leukemia
156
Chronic Myelogenous Leukemia
21
Colorectal Cancer
75
Gastrointestinal Cancer
70
General
246
Head and Neck Cancers
34
Hematologic Malignancies
79
Hodgkin Lymphoma
18
Immunotherapy
88
Kidney Cancer
364
Liver Cancer
11
Lymphoma
145
Melanoma and Skin Cancer
51
Multiple Myeloma
338
Myeloproliferative Disease
15
News
115
Non-Hodgkin Lymphoma
45
Non-Small Cell Lung Cancer
267
Other
110
Ovarian Cancer
10
Pancreatic Cancer
54
Patient Resources
27
Prostate Cancer
148
Small Cell Lung Cancer
58
Soft Tissue Sarcoma
9
Supportive Care
38
Testicular Cancer
2
Urology
6
Uterine Cancer
2
About
Contact
PharmaMar
Subscribe
0
My videos
0:04:01
Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin
Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new drug.
Small Cell Lung Cancer
61 Views
3 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:02:13
Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved
Small Cell Lung Cancer
39 Views
3 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:07:54
Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin
Small Cell Lung Cancer
46 Views
3 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:29:12
Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer
425 Views
6 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:28:53
Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer
866 Views
6 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:00:28
Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm
Small Cell Lung Cancer
577 Views
6 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login